GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LigaChem Biosciences Inc (XKRX:141080) » Definitions » Debt-to-Equity

LigaChem Biosciences (XKRX:141080) Debt-to-Equity : 0.02 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is LigaChem Biosciences Debt-to-Equity?

LigaChem Biosciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩11,975 Mil. LigaChem Biosciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩129 Mil. LigaChem Biosciences's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩627,738 Mil. LigaChem Biosciences's debt to equity for the quarter that ended in Mar. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for LigaChem Biosciences's Debt-to-Equity or its related term are showing as below:

XKRX:141080' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.05   Max: 0.45
Current: 0.02

During the past 12 years, the highest Debt-to-Equity Ratio of LigaChem Biosciences was 0.45. The lowest was 0.00. And the median was 0.05.

XKRX:141080's Debt-to-Equity is ranked better than
87.78% of 1072 companies
in the Biotechnology industry
Industry Median: 0.14 vs XKRX:141080: 0.02

LigaChem Biosciences Debt-to-Equity Historical Data

The historical data trend for LigaChem Biosciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LigaChem Biosciences Debt-to-Equity Chart

LigaChem Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.04 0.05 0.06 0.09

LigaChem Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.08 0.09 0.02

Competitive Comparison of LigaChem Biosciences's Debt-to-Equity

For the Biotechnology subindustry, LigaChem Biosciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LigaChem Biosciences's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LigaChem Biosciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where LigaChem Biosciences's Debt-to-Equity falls into.



LigaChem Biosciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

LigaChem Biosciences's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LigaChem Biosciences's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LigaChem Biosciences  (XKRX:141080) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


LigaChem Biosciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of LigaChem Biosciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


LigaChem Biosciences (XKRX:141080) Business Description

Traded in Other Exchanges
N/A
Address
8-26 Munpyeongseo-ro, Daedeok-gu, Daejeon, KOR, 34302
LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.

LigaChem Biosciences (XKRX:141080) Headlines

No Headlines